• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/9

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

9 Cards in this Set

  • Front
  • Back
What are the 5 general principles of organ transplant therapy?

What cells primarily mediate graft rejection?
1. ABO & HLA match
2. Multi-drug immune suppression
- diff drugs w/ diff toxicities
- lower doses of each possible i/combo
3. immunosupp. needs to be more robust early on
4. pts are monitored for transplant rejection using various assays.
5. if drug toxicity is detected, then the therapy should be stopped/modified.

T-cells
What does formation of the TCR/CD3/antigen/MHC complex result in?

What does this molecule do?

What does IL-2 do? (2)
calcineurin activation in the T-cell cytoplasm.

dephos transcription factor NF-AT --> enters nucleus --> ramps up IL-2 production.`

- stim clonal expansion of T-cells & other immune cells
- sim 'target of rapamycin' (TOR) which regulates mRNA translation.
What are the three (general) different regimens for employing immunosuppressant drugs?
Drug classes involved?
induction:
- steroids
- antibodies to IL-2
maintenance
- calcineurin inhib
- steroids
- antimetabolite
rescue/rejection
- steroids
Daclizumab, Basiliximab
- what are they?
- monoclonal antibodies targeted against IL-2 receptor on the surface of activated T-cells
What are the two calcineurin inhibitors commonly used?
- mech?
- side effects?

Antimetabolites in Maintenance therapy? (2)
- how do they work?
- side effects?
Tacrolimus, cyclosporin
- b/ immunophilins and then inhib calcineurin
- impaired kidney function

mycophenolate
- compet inhib enzyme that lymphocytes require for DNA synth that other cells don't need

azathiprine
- incorporated into DNA, inhibiting it's proper function.

There are some signif side effects, but they're less problematic than the steroids and calcineurin inhibitors.
Why are TOR inhibitors being actively sought?

What are two examples?
- mech?
the calcineurin inhibitors are pretty nephrotoxic and steroids are a pain in the ass.

sirolimus, everolimus
- b/ FKBP-12 just like tacrolimus, but they inhibit TOR not calcineurin.
--> blocks G1->S, and suppressess growth of smooth muscle and endothelial cells --> \graft atherosclerosis.
What are the four principal categories of rejection?

Characterize them.
hyperacute, acute cellular, acute humoral, chronic.

hyperacute:
- preformed antibodies
- v.fast (ABO, HLA, endothelial)

acute cellular:
- T-cell mediated
- 3-6 months post-txp
- lesions at txp site filled w/ macroP and lymphocytes

acute humoral:
- antibodies
- days to weeks post-txp

chronic:
- unclear mechanism
Define rejection rescue therapy (and the preferred agents (3))

What is cytokine release syndrome?
tx w/ antilymphocytic antibodies to reduce their lvls.
**Thymoglobulin causes complement dependent oposonization and lysis of lymphocytes

OKT3 (muromonab-CD3) --> renders the T-cells unable to respond to an antigen challenge.
- intial binding results in activation of the T-cell --> cytokine release syndrome

ATGAM; works similiarly to thymoglobulin.
The four types of rejection are hyperacute, acute cellular, acute humoral, and chronic. How are they tx'ed?
Acute Cellular
- IV methylprednisolone or rescue therapy

Acute humoral:
- IV methylprednisolone w/ oral prednisone.
- Plasmapheresis
- consider rituximab if all else fails; capable of killing B-cells.

Chronic (aka CAV):
- angioplasty if there is focal ischemia
- TOR inhibitors have been found to reduce/reverse CAV